Advertisement
Subscribe now
Log in
November 16, 2026 15:30
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Media OutReach Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Your Consultant
KPMG
PwC
Indochine Counsel
Vilasia
Ansarada
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
CSR
Swing for the Kids
World News
Tags
Zybrivo
Innovent receives positive European opinion for Zybrivo lung cancer treatment
November 16, 2026 | 15:16
Innovent Biologics received a positive opinion from European regulators recommending Zybrivo for the first-line treatment of non-squamous non-small cell lung cancer, according to a 16 November announcement.
Latest News
Thunes Expands Real-Time Payouts to Bhutan, Unlocking the Nation's Remittance Market
Thailand approves Specialised Therapeutics sarcoma therapy Yondelis for adult patients
Innovent receives positive European opinion for Zybrivo lung cancer treatment
Hanoi solo travel accommodation searches rise 22% in late 2026
Mobile Version